The MassARRAY® SARS-CoV-2 Panel enables high-throughput, low-cost molecular detection with built-in resilience against the emergence of new variants. Available for in vitro diagnostic use under Emergency Use Authorization by the F.D.A. and CE-IVD marked in Europe.
Discover how labs across the world use our core technology to achieve faster decisions and greater productivity in precision medicine.
For IVD use under FDA EUA and CE-IVD marked in Europe. Alleviate testing material shortages with a secure supply of instruments and reagents. Test thousands of samples per day on a single instrument at a low cost…
Learn MoreDr. Martin Stürmer discusses the effects of emerging SARS-CoV-2 variants on diagnostic methods and the clinical utility of detecting and discriminating them…
Register Now